Literature DB >> 31270974

2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

.   

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection is high in middle-aged and elderly patients. These practice guidelines will provide useful and constructive advice for the clinical management of patients with HCC. A total of 44 experts in hepatology, oncology, surgery, radiology, and radiation oncology in the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2014 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions.
Copyright © 2019 The Korean Society of Radiology.

Entities:  

Keywords:  Carcinoma, hepatocellular; Diagnosis; Guidelines; Management

Mesh:

Year:  2019        PMID: 31270974      PMCID: PMC6609431          DOI: 10.3348/kjr.2019.0140

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  710 in total

1.  Liver transplantation for hepatocellular carcinoma.

Authors:  H Bismuth; P E Majno; R Adam
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 3.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

4.  Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma.

Authors:  J M Llovet; M Sala; L Castells; Y Suarez; R Vilana; L Bianchi; C Ayuso; V Vargas; J Rodés; J Bruix
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

Review 5.  [Hepatotoxicity caused by therapeutic doses of paracetamol in alcoholics. Report of 2 cases of fatal hepatitis in cirrhosis].

Authors:  A Mofredj; J F Cadranel; B Darchy; J C Barbare; A Cazier; V Pras; M Biour
Journal:  Ann Med Interne (Paris)       Date:  1999-10

6.  Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Authors:  J M Llovet; J Fuster; J Bruix
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

7.  A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma.

Authors:  S H Cheng; Y M Lin; V P Chuang; P S Yang; J C Cheng; A T Huang; J L Sung
Journal:  J Gastroenterol Hepatol       Date:  1999-10       Impact factor: 4.029

8.  Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal.

Authors:  O Farges; B Malassagne; J F Flejou; S Balzan; A Sauvanet; J Belghiti
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

9.  Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors.

Authors:  R T Poon; S T Fan; C M Lo; C L Liu; J Wong
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

10.  Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C.

Authors:  S Kubo; T Yamamoto; T Ikebe; T Shuto; K Hirohashi; H Tanaka; T Tsukamoto; K Wakasa; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  1999-10
View more
  45 in total

1.  The Effect of 5A nursing intervention on living quality and self-care efficacy of patients undergoing chemotherapy after hepatocellular carcinoma surgery.

Authors:  Xuejuan Zhang; Min Lai; Donghan Wu; Pidan Luo; Shuixi Fu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 2.  Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.

Authors:  Takahiro Yamasaki; Issei Saeki; Yurika Yamauchi; Toshihiko Matsumoto; Yutaka Suehiro; Tomokazu Kawaoka; Shinsuke Uchikawa; Akira Hiramatsu; Hiroshi Aikata; Kazufumi Kobayashi; Takayuki Kondo; Sadahisa Ogasawara; Tetsuhiro Chiba; Taro Takami; Kazuaki Chayama; Naoya Kato; Isao Sakaida
Journal:  Liver Cancer       Date:  2022-02-22       Impact factor: 12.430

3.  Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes.

Authors:  Dong Ho Lee; Jing Woong Kim; Jeong Min Lee; Jong Man Kim; Min Woo Lee; Hyunchul Rhim; Young Hoe Hur; Kyung-Suk Suh
Journal:  Liver Cancer       Date:  2021-01-14       Impact factor: 11.740

4.  Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.

Authors:  Sang Min Lee; Jeong Min Lee; Su Joa Ahn; Hyo Jin Kang; Hyun Kyung Yang; Jeong Hee Yoon
Journal:  Korean J Radiol       Date:  2021-03-09       Impact factor: 3.500

5.  Non-contrast Magnetic Resonance Imaging versus the Multiphase Computed Tomography with Respect to the Asia-Pacific Clinical Practice Guidelines: A Diagnostic Performance Study for Liver Cancer.

Authors:  Yang Wei; Liu Haifen; Li Xiang; Zhang Shutong; Chen Yanhao; Wang Xiang
Journal:  Turk J Gastroenterol       Date:  2021-03       Impact factor: 1.852

Review 6.  Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia-Pacific Region: A Review and Multidisciplinary Expert Opinion.

Authors:  Sadahisa Ogasawara; Su-Pin Choo; Jiang-Tao Li; Changhoon Yoo; Bruce Wang; Dee Lee; Pierce K H Chow
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

Review 7.  Recent advances in the surgical management of hepatocellular carcinoma.

Authors:  Georgios K Glantzounis; Anastasia Karampa; Dimitra V Peristeri; George Pappas-Gogos; Kostas Tepelenis; Petros Tzimas; Dimitrios J Cyrochristos
Journal:  Ann Gastroenterol       Date:  2021-05-27

8.  An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist.

Authors:  Haiyang Chen; Meng Tao; Ding Li; Jing Han; Cheng Cheng; Yanfang Ma; Yingxi Wu; Vishal G Shelat; Francisco Tustumi; Sanjaya K Satapathy; Koo Jeong Kang; Qiming Wang
Journal:  Ann Transl Med       Date:  2021-06

9.  Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma.

Authors:  Jae Hyun Yoon; Won Jae Lee; Sun Min Kim; Kwang Tack Kim; Sung Bum Cho; Hee Joon Kim; Yang Seok Ko; Hyun Yi Kook; Chung Hwan Jun; Sung Kyu Choi; Ban Seok Kim; Seo Yeon Cho; Hye-Su You; Yohan Lee; Seyeong Son
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

Review 10.  Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria.

Authors:  Yanzhao Zhou; Yi Yang; Bingyan Zhou; Zhengzheng Wang; Ruili Zhu; Xun Chen; Jingzhong Ouyang; Qingjun Li; Jinxue Zhou
Journal:  J Hepatocell Carcinoma       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.